301 related articles for article (PubMed ID: 34718238)
1. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
Zhu Z; Ling X; Zhou H; Zhang C; Yan W
Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates hypoxia/reoxygenation‑induced myocardial injury.
Wei W; Peng J; Li J
Mol Med Rep; 2019 Dec; 20(6):4821-4830. PubMed ID: 31638219
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
Shi X; Liu Z; Li J
Mol Med Rep; 2020 Oct; 22(4):3307-3315. PubMed ID: 32945482
[TBL] [Abstract][Full Text] [Related]
7. Resina draconis inhibits the endoplasmic-reticulum-induced apoptosis of myocardial cells via regulating miR-423-3p/ERK signaling pathway in a tree shrew myocardial ischemia- reperfusion model.
Yang TR; Zhang T; Mu NH; Ruan LB; Duan JL; Zhang RP; Miao YB
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180066
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
Wang K; Zhu Y
J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
Zhu Z; Ling X; Zhou H; Zhang C
Exp Ther Med; 2021 Feb; 21(2):132. PubMed ID: 33376514
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
Cai S; Liu Y; Cheng Y; Yuan J; Fang J
J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
[TBL] [Abstract][Full Text] [Related]
12. GAS5 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via upregulating LAS1 expression.
Liu SD; Meng WX; Xu L; Chi C; Sun X; Liu HY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8447-8453. PubMed ID: 30556886
[TBL] [Abstract][Full Text] [Related]
13. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 mediates the protection of kaempferol against hypoxia/reoxygenation-induced cardiomyocyte injury via promoting Notch1/PTEN/AKT signaling pathway.
Huang J; Qi Z
PLoS One; 2020; 15(11):e0241007. PubMed ID: 33151961
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of total paeony glycoside on ischemia/reperfusion injury in H9C2 cells via inhibition of the PI3K/Akt signaling pathway.
Shen P; Chen J; Pan M
Mol Med Rep; 2018 Sep; 18(3):3332-3340. PubMed ID: 30066927
[TBL] [Abstract][Full Text] [Related]
18. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
Wang Y; Che J; Zhao H; Tang J; Shi G
Biochem Biophys Res Commun; 2018 Sep; 503(4):3219-3224. PubMed ID: 30146261
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
Wu ZL; Davis JRJ; Zhu Y
Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
[TBL] [Abstract][Full Text] [Related]
20. Salidroside mitigates hypoxia/reoxygenation injury by alleviating endoplasmic reticulum stress‑induced apoptosis in H9c2 cardiomyocytes.
Sun MY; Ma DS; Zhao S; Wang L; Ma CY; Bai Y
Mol Med Rep; 2018 Oct; 18(4):3760-3768. PubMed ID: 30132527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
